DSM-5-TR diagnostic criteria summary
Bipolar II Disorder requires:
- At least one hypomanic episode:
- Three or more (4 if mood only irritable) of: inflated self-esteem, decreased need for sleep, pressured speech, flight of ideas, distractibility, increased goal-directed activity, excessive risk-taking
- Unequivocal change from baseline observable by others
- NOT severe enough to cause marked impairment, hospitalization, or psychotic features
- No history of a manic episode. If full mania has ever occurred, the diagnosis is Bipolar I (F31.x).
- The depression and hypomania are not better explained by schizoaffective disorder or other psychotic disorders.
- Symptoms cause clinically significant distress or impairment, typically during depressive episodes.
Source: American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), p. 157–168.
Differential diagnosis
- F31.1 Bipolar I Disorder, when any lifetime full manic episode (7+ days, marked impairment, psychotic features, or hospitalization) is identified.
- F33.x Major Depressive Disorder, when no lifetime hypomanic or manic episode is identified. Subtle hypomania often missed without targeted screening.
- F60.3 Borderline Personality Disorder, affective shifts in BPD are brief (hours-to-days) and reactive to interpersonal triggers; Bipolar II hypomania is sustained mood elevation lasting days-to-weeks.
- F34.0 Cyclothymic Disorder, chronic mood instability with hypomanic and depressive symptoms that don't meet full episode criteria.
- Substance/Medication-Induced Bipolar (F19.x), stimulants, corticosteroids; antidepressant-induced hypomania persisting beyond pharmacologic effect remains coded as bipolar.
Common comorbidities
Bipolar II has very high lifetime comorbidity. Common co-occurring conditions: Generalized Anxiety Disorder (F41.1), Panic Disorder (F41.0), Substance Use Disorders (F10–F19, especially alcohol), ADHD (F90.x), Eating Disorders (F50.x), and Borderline Personality Disorder (F60.3, particularly common, ~20% comorbidity). Co-administer PHQ-9, GAD-7, AUDIT, and (where indicated) ASRS alongside the MDQ.
Sources
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), F31.81, p. 157–168.
- Hirschfeld, R. M., et al. (2000). Development and validation of the Mood Disorder Questionnaire. American Journal of Psychiatry, 157(11), 1873–1875.
- Centers for Disease Control and Prevention. ICD-10-CM Official Coding Guidelines.